Bone marrow aspiration has been shown to be a safe and effective means to harvest nucleated cells. Nucleated cells are only present in a low concentration in a bone marrow

aspirate.

The BioCUE BMA Concentration System was designed to address this by providing a rapid, efficient concentration of autologous bone marrow aspirate (BMA).

Bone marrow aspirate contains mesenchymal stem cells, which are able to proliferate and differentiate into a number of different soft and hard tissues. Utilizing BioCUE technology,

these stem cells can be concentrated at the patient’s point of care. Clinical evidence suggests cellular concentration positively affects the clinical outcome of bone grafting

procedures.

Product Features :

• 9x nucleated cells increase over baseline.
• 5x Platelets increase over baseline.
• 6 ml of autologous concentrated bone marrow (cBMA) output from 50 ml bone marrow input.
• 15 minutes centrifuge process.
• All the components necessary to obtain and process autologous bone marrow aspirate at a patient’s point-of-care are included in the kit.

Possible applications of Concentrated Bone

Marrow Aspirate :

• Delayed union and nonunion
• Avascular necrosis
• Bone cysts

BioCUE Brochure